JOHNSON & JOHNSON revenue for the last year amounted to 1.85 T MXN, the most of which — 1.19 T MXN — came from its highest performing source at the moment, Innovative Medicine, the year earlier bringing 930.09 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought JOHNSON & JOHNSON 1.05 T MXN, and the year before that — 788.86 B MXN.